Sandro Santagata MD PhD

Sandro Santagata MD PhD

Harvard University

H-index: 81

North America-United States

About Sandro Santagata MD PhD

Sandro Santagata MD PhD, With an exceptional h-index of 81 and a recent h-index of 63 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Cancer, Tissue Biology, Diagnostic Pathology, Systems Biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Genomic and immunophenotypic landscape of acquired resistance to PD-(L) 1 blockade in non–small-cell lung cancer

NAB2::STAT6 fusions and genome‐wide DNA methylation profiling: Predictors of patient outcomes in meningeal solitary fibrous tumors

Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates

Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancer

Distribution of Copy Number Variants and Impact of Chromosome Arm Call Thresholds for Meningioma

Impact of Chromosome Copy Number Thresholds on Meningioma Molecular Classification

STMND1 is A Phylogenetically Ancient Stathmin which Localizes to Motile Cilia and Exhibits Nuclear Translocation that Is Inhibited When Soluble Tubulin Concentration Increases

Integrating Systemic Therapies into the Multimodality Therapy of Patients with Craniopharyngioma

Sandro Santagata MD PhD Information

University

Position

Harvard Medical School

Citations(all)

24496

Citations(since 2020)

14294

Cited By

14596

hIndex(all)

81

hIndex(since 2020)

63

i10Index(all)

175

i10Index(since 2020)

162

Email

University Profile Page

Google Scholar

Sandro Santagata MD PhD Skills & Research Interests

Cancer

Tissue Biology

Diagnostic Pathology

Systems Biology

Top articles of Sandro Santagata MD PhD

Title

Journal

Author(s)

Publication Date

Genomic and immunophenotypic landscape of acquired resistance to PD-(L) 1 blockade in non–small-cell lung cancer

Journal of Clinical Oncology

Biagio Ricciuti

Giuseppe Lamberti

Sreekar R Puchala

Navin R Mahadevan

Jia-Ren Lin

...

2024/1/11

NAB2::STAT6 fusions and genome‐wide DNA methylation profiling: Predictors of patient outcomes in meningeal solitary fibrous tumors

Brain Pathology

Kathryn L Eschbacher

Quynh T Tran

Evgeny A Moskalev

Sarah Jenkins

Karen Fritchie

...

2024/3/24

Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates

Clinical Cancer Research

Candace L Haddox

Michael J Nathenson

Emanuele Mazzola

Jia-Ren Lin

Joanna Baginska

...

2024/2/23

Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancer

NPJ Breast Cancer

Jennifer L Guerriero

Jia-Ren Lin

Ricardo G Pastorello

Ziming Du

Yu-An Chen

...

2024/1/2

Distribution of Copy Number Variants and Impact of Chromosome Arm Call Thresholds for Meningioma

Wenya Linda Bi

Ruchit Patel

Hia Ghosh

David Meredith

Scott Ryall

...

2024/3/5

Impact of Chromosome Copy Number Thresholds on Meningioma Molecular Classification

Journal of Neurological Surgery Part B: Skull Base

Ruchit V Patel

Hia S Ghosh

Sandro Santagata

Wenya Linda Bi

2024/2

STMND1 is A Phylogenetically Ancient Stathmin which Localizes to Motile Cilia and Exhibits Nuclear Translocation that Is Inhibited When Soluble Tubulin Concentration Increases

Molecular Biology of the Cell

Xiang Deng

Bryan O Seguinot

Gary Bradshaw

Jong Suk Lee

Shannon Coy

...

2024/6/1

Integrating Systemic Therapies into the Multimodality Therapy of Patients with Craniopharyngioma

David Gritsch

Sandro Santagata

Priscilla K Brastianos

2024/2/1

Abstract B075: Spatial genomics identifies cancer cell cytokines regulating ovarian cancer immunity

Cancer Research

Gurkan Mollaoglu

Alexander Tepper

Hunter Potak

Luisanna Pia

Angelo Amabile

...

2024/3/4

Abstract A042: Characterization of the hormone receptor-positive breast tumor immune microenvironment using single cell transcriptomics and multiplex immunofluorescence

Cancer Research

Daniel Michaud

Kenichi Shimada

Kelly Zheng

Cheryl Gu

Yvonne Cui

...

2024/2/1

Pilot trial of perampanel on peritumoral hyperexcitability and clinical outcomes in newly diagnosed high-grade glioma

medRxiv

Steven Tobochnik

Michael S Regan

Maria KC Dorotan

Dustine Reich

Emily Lapinskas

...

2024/4/12

Abstract 2329 Mechanisms regulating copper-dependent cell death

Journal of Biological Chemistry

Peter Tsvetkov

Nolan Bick

Margaret Dreishpoon

Douglas Warui

Naama Kanarek

...

2024/3/1

Cell state dependent effects of Bmal1 on melanoma immunity and tumorigenicity

Nature communications

Xue Zhang

Shishir M Pant

Cecily C Ritch

Hsin-Yao Tang

Hongguang Shao

...

2024/1/20

Abstract LB311: Multimodal spatial profiling reveals the emergence of an immune suppressive microenvironment at the initial stages of high-grade serous ovarian cancer development

Cancer Research

Tanjina Kader

Jia-Ren Lin

Shannon Coy

Clemens Hug

Yu-An Chen

...

2024/4/5

Systematic characterization of antibody–drug conjugate targets in central nervous system tumors

Neuro-oncology

Shannon Coy

Jong Suk Lee

Sabrina J Chan

Terri Woo

Jacquelyn Jones

...

2024/3/1

High-plex immunofluorescence imaging and traditional histology of the same tissue section for discovering image-based biomarkers

Nature cancer

Jia-Ren Lin

Yu-An Chen

Daniel Campton

Jeremy Cooper

Shannon Coy

...

2023/7

896 Characterizing macrophage heterogeneity in HR+/HER2-metastatic breast cancer reveals novel mechanisms of resistance

Kelly F Zheng

Kenichi Shimada

Madeline G Townsend

Tianyu Li

Nabihah Tayob

...

2023/11/1

Genomic analysis of spinal meningiomas: correlation with histopathological grade

Journal of Neurosurgery: Spine

Joseph Driver

Sandro Santagata

Wenya Linda Bi

John H Chi

2023/8/25

BIOM-55. TARGETED GENE EXPRESSION PROFILING PREDICTS MENINGIOMA OUTCOMES AND RADIOTHERAPY RESPONSES

Neuro-Oncology

William Chen

Abrar Choudhury

Mark W Youngblood

Mei-Yin Polly

Calixto-Hope Lucas

...

2023/11/1

Comprehensive analysis reveals potential therapeutic targets and an integrated risk stratification model for solitary fibrous tumors

Nature Communications

Renjing Zhang

Yang Yang

Chunfang Hu

Mayan Huang

Wenjian Cen

...

2023/11/18

See List of Professors in Sandro Santagata MD PhD University(Harvard University)